SCOPUS 정보 검색 플랫폼

Expert Review of Neurotherapeutics

Volumn 1, Issue 2, 2001, Pages 153-159

Galantamine: A new treatment for Alzheimer's disease

(1) Wilkinson, David G a

a UNIVERSITY OF SOUTHAMPTON (United Kingdom)

Author keywords

Alzheimer's disease; Cholinesterase inhibitor; Galantimine

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; GALANTAMINE; NICOTINE; NICOTINIC RECEPTOR;

ALLOSTERISM; ALZHEIMER DISEASE; ANOREXIA; BEHAVIOR; COGNITION; COMPETITIVE INHIBITION; DIARRHEA; DRUG CLEARANCE; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; NAUSEA; NEUROTRANSMISSION; PHARMACODYNAMICS; REVIEW; VOMITING;

EID: 0035741740 PISSN: 14737175 EISSN: None Source Type: Journal
DOI: 10.1586/14737175.1.2.153 Document Type: Review

Times cited : (11)

References (27)

1
- 0025918759
- The prevalence of dementia in Europe: A collaborative study of 1980-1990 findings
- (1991) Int. J. Epidemiol. , vol.20 , pp. 736-748
- Hoffman, A.¹ Rocca, W.A.² Brayne, C.³

2
- 0027358213
- Alzheimer's disease: The burden of illness in England
- (1993) Health Trends , vol.25 , pp. 31-37
- Gray, A.M.¹ Fenn, P.²

3
- 0030801772
- Diagnosis and treatment of Alzheimer disease and related disorders
- (1997) JAMA , vol.278 , pp. 1363-1371
- Small, G.W.¹ Rabins, P.V.² Barry, P.B.³

4
- 0019972810
- The cholinergic hypothesis of geriatric memory dysfunction
- (1982) Science , vol.217 , pp. 408-417
- Bartus, B.T.¹ Dean, R.I.² Beer, B.³

5
- 0022899577
- Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type
- (1986) N. Engl. J. Med. , vol.315 , pp. 1241-1245
- Summers, W.K.¹ Majovski² Marsh, G.M.³

6
- 0033224560
- The pharmacology of donepezil: A new treatment for Alzheimer's disease
- (1999) Exp. Opin. Pharmacother. , vol.1 , Issue.1 , pp. 121-135
- Wilkinson, D.G.¹

7
- 0033668050
- Galantamine: A review of its use in Alzheimer's disease
- (2000) Drugs , vol.60 , Issue.5 , pp. 1095-1122
- Scott, L.J.¹ Goa, K.L.²

8
- 0033815406
- Review of the acetylcholinesterase inhibitor galantamine
- (2000) Exp. Opin. Invest. Drugs , vol.9 , Issue.10 , pp. 2393-2402
- Sramek, J.J.¹ Frackiewicz, E.J.² Curler, N.R.³

9
- 0025765379
- Galanthamine: Pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice
- (1991) Neuropharmacology , vol.30 , pp. 447-450
- Bickel, U.¹ Thomsen, T.² Fischer, J.P.³

10
- 0030922512
- Pharmacokinetics and metabolism of galanthamine
- (1997) Drugs of Today , vol.33 , Issue.4 , pp. 265-272
- Kewitz, H.¹

11
- 0030018834
- Galanthamine
- (1996) Drugs Aging , vol.1 , pp. 61-67
- Fulton, B.¹ Benfield, P.²

12
- 0025572193
- Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans
- (1990) Eur. J. Clin. Pharmacol. , vol.39 , pp. 603-605
- Thomsen, T.¹ Bickel, U.² Fischer, J.P.³

13
- 0031043364
- Galantamine in Alzheimer's disease. A new alternative to tacrine?
- (1997) CNS Drugs , vol.7 , pp. 89-97
- Rainer, M.¹

14
- 0034732104
- Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
- (2000) Eur. J. Pharmacol. , vol.393 , pp. 165-170
- Maelicke, A.¹ Albuquerque, E.X.²

15
- 0032910197
- The cholinergic hypothesis of Alzheimer's disease: A review of progress
- (1999) J. Neurol. Neurosurg. Psychiatry , vol.66 , pp. 137-147
- Francis, P.T.¹ Palmer, A.M.² Snape, M.³ Wilcock, G.⁴

16
- 0030751425
- Nicotinic involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics
- (1997) Drugs Aging , vol.11 , Issue.3 , pp. 206-228
- Newhouse, P.A.¹ Potter, A.² Levin, E.D.³

17
- 0031928549
- Nicotinic acetylcholine involvement in cognitive function in animals
- (1998) Psychopharmacology (Berl.). , vol.138 , pp. 217-230
- Levin, E.D.¹ Simon, B.B.²

18
- 0034720816
- Galantamine in AD. A 6-month randomized, placebo-controlled trial with a 6-month extension
- (2000) Neurology , vol.54 , pp. 2261-2268
- Raskind, M.A.¹ Peskind, E.R.² Wessel, T.³

19
- 0000406791
- Efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease; a multicentre randomised controlled trial
- (2000) Br. Med. J. , vol.321 , pp. 1-7
- Wilcock, G.¹ Lilienfield, S.² Gaens, E.³

20
- 0034720864
- A 5-month, randomized, placebo-controlled trial of galantamine in AD
- (2000) Neurology , vol.54 , pp. 2269-2276
- Tariot, P.N.¹ Solomon, P.R.² Morris, J.C.³

21
- 0034771057
- Effects of a flexible galantamine dose on cognition and function in Alzheimer's disease: A randomised, controlled trial
- (2001) J. Neurol. Neurosurg. Psychiatry , vol.71 , pp. 589-595
- Rockwood, K.¹ Minzer, J.² Truyen, L.³ Wessel, T.⁴ Wilkinson, D.⁵

22
- 0034810025
- Galantamine: A randomised, double blind, dose finding trial in patients with Alzheimer's disease
- (2001) Int. J. Geriatr. Psychiat. , vol.16 , pp. 852-857
- Wilkinson, D.¹ Murray, J.²

23
- 0033813557
- Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
- (2000) Dementia Geriatr. Cognitive Disord. , vol.11 , pp. 11-18
- Maelicke, A.¹

24
- 0009484853
- Galantamine produces significant improvement in patients with 'advanced moderate' dementia
- Nice, France. Sept
- (2001) Poster, International Psychogeriatric Association
- Wilkinson, D.¹ Schwalen, S.²

25
- 0000993877
- Donepezil enhances global function, cognition and activities of daily living compared with placebo in a one-year, double-blind trial in patients with mild-to-moderate Alzheimer's disease
- (2001) Neurology , vol.57 , pp. 489-496
- Winblad, B.¹ Engedel, K.² Soininen, H.³

26
- 0003276402
- Galantamine shows efficacy in patients with Alzheimer's disease with cerebrovascular disease or probable vascular dementia
- Philadelphia, USA. May
- (2001) Poster American Academy of Neurology
- Erkinjuntti, T.¹ Lilienfield, S.²

27
- 0034877979
- Pharmacotherapy of Alzheimer' disease: Is there a need to redefine treatment success?
- (2001) Int. J. Geriatr. Psychiat. , vol.16 , Issue.7 , pp. 653-666
- Winblad, B.¹ Brodaty, H.² Gauthier, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.